ES2136755T3 - Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases. - Google Patents

Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases.

Info

Publication number
ES2136755T3
ES2136755T3 ES95103319T ES95103319T ES2136755T3 ES 2136755 T3 ES2136755 T3 ES 2136755T3 ES 95103319 T ES95103319 T ES 95103319T ES 95103319 T ES95103319 T ES 95103319T ES 2136755 T3 ES2136755 T3 ES 2136755T3
Authority
ES
Spain
Prior art keywords
pna
protection group
synthesis
nucleic acids
amino protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95103319T
Other languages
English (en)
Inventor
Gerhard Dr Breipohl
Eugen Dr Uhlmann
Jochen Dr Knolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2136755T3 publication Critical patent/ES2136755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA ELABORACION DE OLIGOMEROS PNA DONDE R0 SIGNIFICA HIDROGENO, ALCANOIL, ALCOXICARBONIL, CICLOALCANOIL, AROIL, HETEROAROIL, O UN GRUPO, QUE ES ADECUADO PARA LA RECEPCION INTRACELULAR DE OLIGOMERO, A Y Q SON RESTOS AMINOACIDOS, K Y L SON 0 HASTA 20, N SIGNIFICA 1 HASTA 50, B ES UNA NUCLEOBASE HABITUAL EN LA QUIMICA DE NUCLEOTIDOS Y Q0 SIGNIFICA OH, NH2 O ALQUILAMINO QUE PUEDE SER SUSTITUIDO POR ON O NH2. CON ELLO SE DESDOBLAN LOS RESTOS AMINOACIDO Y LOS COMPONENTES DONDE PG ES UN GRUPO DE PROTECCION AMINO INESTABLE DE BASE Y B'' ES UNA NUCLEOBASE PROTEGIDA EN AMINOFUNCION EXOCICLICA, EN FORMA DE ETAPAS DE ACUERDO CON EL METODO DE FASE SOLIDA SOBRE UN SOPORTE POLIMERO, QUE ESTA PROVISTO CON UN GRUPO DE ANCLAJE. SIENDO ACOPLADO Y, DESPUES DE TERMINADA LA CONSTITUCION, SE DESDOBLAN LOS COMPUESTOS OBJETIVO POR MEDIO DE UNA REACCION DE DESDOBLAMIENTO DE SOPORTE POLIMERO. SE DESCRIBEN ADEMAS PRODUCTOS INTERMEDIOS DE OLIGOMEROS PNA ASI COMO PROCESO PARA SU ELABORACION.
ES95103319T 1994-03-14 1995-03-08 Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases. Expired - Lifetime ES2136755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4408533A DE4408533A1 (de) 1994-03-14 1994-03-14 PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe

Publications (1)

Publication Number Publication Date
ES2136755T3 true ES2136755T3 (es) 1999-12-01

Family

ID=6512697

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95103319T Expired - Lifetime ES2136755T3 (es) 1994-03-14 1995-03-08 Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases.

Country Status (12)

Country Link
US (2) US6121418A (es)
EP (1) EP0672701B1 (es)
JP (1) JP4098836B2 (es)
AT (1) ATE182602T1 (es)
AU (1) AU683714B2 (es)
CA (1) CA2144473C (es)
DE (2) DE4408533A1 (es)
DK (1) DK0672701T3 (es)
ES (1) ES2136755T3 (es)
FI (1) FI120262B (es)
GR (1) GR3031265T3 (es)
NO (1) NO321035B1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7825215B1 (en) 1993-04-26 2010-11-02 Peter E. Nielsen Substituted nucleic acid mimics
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DE69632324T2 (de) * 1995-06-07 2005-06-16 PerSeptive Biosystems, Inc., Framingham Pna-dna-chimäre und pna-synthone zu deren herstellung
DE19712530A1 (de) * 1997-03-25 1998-10-01 Boehringer Mannheim Gmbh Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren
US20030228619A1 (en) * 2002-06-10 2003-12-11 Xenoport, Inc. Peptide nucleic acids as tags in encoded libraries
DE60330182D1 (de) * 2002-09-08 2009-12-31 Applera Corp Festphasengebundene PNA-Dimere und deren Synthese
CA2640976A1 (en) * 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
WO2012138955A2 (en) * 2011-04-08 2012-10-11 Ly Danith H CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS
CN104211619B (zh) * 2014-08-19 2016-08-17 苏州维泰生物技术有限公司 一种N-(2-Fmoc-氨乙基)甘氨酸甲酯盐酸盐的合成方法
CN110740994A (zh) * 2017-03-23 2020-01-31 特鲁科德基因修复公司 具有受正交保护的酯部分的肽核酸(pna)单体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT41715A (en) * 1984-12-28 1987-05-28 Monsanto Co Process for preparing n-substituted alpha-aminoacids and derivatives thereof
DE3635670A1 (de) 1986-10-21 1988-04-28 Hoechst Ag Synthese von peptid-aminoalkylamiden und peptidhydraziden mittels festphasenmethode
DE3713433A1 (de) 1987-04-22 1988-11-03 Werner Grossmann Einrichtung zum entfernen von schmutzteilchen vom plattenzylinder einer offsetdruckmaschine
EP0322348B1 (de) 1987-12-22 1994-02-02 Hoechst Aktiengesellschaft Säurelabile Ankergruppen zur Synthese von Peptidamiden mittels Festphasenmethode
DE4016596A1 (de) 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
MX9207334A (es) * 1991-12-18 1993-08-01 Glaxo Inc Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
US5527675A (en) * 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis

Also Published As

Publication number Publication date
DK0672701T3 (da) 2000-01-03
NO950958L (no) 1995-09-15
DE59506432D1 (de) 1999-09-02
EP0672701B1 (de) 1999-07-28
AU1480095A (en) 1995-09-21
ATE182602T1 (de) 1999-08-15
JPH07291909A (ja) 1995-11-07
EP0672701A1 (de) 1995-09-20
CA2144473A1 (en) 1995-09-15
FI120262B (fi) 2009-08-31
US6316595B1 (en) 2001-11-13
CA2144473C (en) 2008-07-15
GR3031265T3 (en) 1999-12-31
FI951129A7 (fi) 1995-09-15
AU683714B2 (en) 1997-11-20
FI951129A0 (fi) 1995-03-10
NO321035B1 (no) 2006-03-06
US6121418A (en) 2000-09-19
NO950958D0 (no) 1995-03-13
JP4098836B2 (ja) 2008-06-11
DE4408533A1 (de) 1995-09-28

Similar Documents

Publication Publication Date Title
ES2132450T3 (es) Sintesis de acidos nucleicos de peptidos o poliamidas (pna) utilizando un grupo protector de amino inestable frente a acidos debiles.
ES2136755T3 (es) Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases.
ES2165357T3 (es) Derivados de metileno-oxiindol y procedimiento de elaboracion.
PA8539401A1 (es) Quinazolinas como inhibidores de mmp-13
ATE499343T1 (de) Stickoxid freistetzende amidin- und enaminverwandte diazeniumdiolate, zubereitungen und verwendungen davon und verfahren zu ihrer herstellung
BR0109922A (pt) Compostos quìmicos
DE69733272D1 (de) N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta-amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen
DE60044367D1 (de) Nichtaggregierende, nichtausschaltende oligomere, nukleotid-analoga enthaltend; verfahren zu deren herstellung und verwendung
CY1109000T1 (el) Διεργασια για παραγωγη σταυρωτα συνδεδεμενου υδροχλωριδιου πολυαλλυλαμινης
BR0109109A (pt) Composto, uso do mesmo, processo para prepará-lo, composição farmacêutica, e, método de tratar um estado doentio mediado por ccr5 em mamìferos
CO4950563A1 (es) Nuevos compuestos
TR200201146T2 (tr) Sertralin hidrokorid polimorfik formları.
ATE209620T1 (de) Verfahren zur herstellung von nitrobiphenylen
Kubik et al. Synthesis of α, α-dialkylated amino acids with adenine or thymine residues a new mild and facile hydrolysis of hydantoins
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
ATE264688T1 (de) Cd28/ctla-4 inhibierende peptidomimetika und diese enthaltende pharmazeutische zusammensetzungen
TR200101771T1 (tr) Uçucu tertiyer amin içermeyen anyonik bir poliüretanın sulu dispersiyonunun hazırlanması için proses.
DE59101851D1 (de) Siliciumdiimid, verfahren zu dessen Herstellung sowie daraus erhaltenes Siliciumnitrid.
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
DE69414348D1 (de) Fluorenonderivate, verfahren zu ihrer herstellung sowie wiederherstellungs- und schutzmittel für zentrale und periphere nervendegenerationen
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
BR0205172A (pt) Processo para a sìntese de esfingosina
BR9808664A (pt) Processo para preparar eprosartan
BR0010652A (pt) Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados
BRPI9807312B8 (pt) derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 672701

Country of ref document: ES